Evaluation of FASN inhibitors by a versatile toolkit reveals differences in pharmacology between human and rodent FASN preparations and in antiproliferative efficacy in vitro vs. in situ in human cancer cells

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

ELSEVIER

1. Academy of Finland [278212, 276509]
2. Institute of Biomedicine
3. Biocenter Finland/DDCB
4. Academy of Finland (AKA) [276509, 278212, 276509, 278212] Funding Source: Academy of Finland (AKA)